TreeWAS – Variant ID: rs10426201

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K80.2 Calculus of gallbladder without cholecystitis	0.000	0.000	1.000
K80.1 Calculus of gallbladder with other cholecystitis	0.000	0.000	1.000
K80 Cholelithiasis	0.000	0.000	1.000
K82 Other diseases of gallbladder	0.000	0.000	1.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.000	0.000	1.000
K82.8 Other specified diseases of gallbladder	0.000	0.004	0.996
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.009	0.991
K82.4 Cholesterolosis of gallbladder	0.000	0.028	0.972
K81 Cholecystitis	0.000	0.040	0.960
K82.9 Disease of gallbladder, unspecified	0.000	0.043	0.957
K81.9 Cholecystitis, unspecified	0.000	0.118	0.882
K82.2 Perforation of gallbladder	0.000	0.125	0.875
K81.0 Acute cholecystitis	0.000	0.152	0.848
K80.4 Calculus of bile duct with cholecystitis	0.000	0.178	0.822
K80.0 Calculus of gallbladder with acute cholecystitis	0.000	0.193	0.807
K82.1 Hydrops of gallbladder	0.000	0.238	0.762
K82.3 Fistula of gallbladder	0.000	0.242	0.758
K83 Other diseases of biliary tract	0.000	0.261	0.739
K81.1 Chronic cholecystitis	0.000	0.283	0.717
K80.3 Calculus of bile duct with cholangitis	0.000	0.283	0.717
K82.0 Obstruction of gallbladder	0.000	0.283	0.717
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.000	0.283	0.717
K81.8 Other cholecystitis	0.000	0.314	0.685
K83.8 Other specified diseases of biliary tract	0.000	0.344	0.656
K83.9 Disease of biliary tract, unspecified	0.000	0.406	0.594
K80.8 Other cholelithiasis	0.000	0.463	0.537
K83.4 Spasm of sphincter of Oddi	0.000	0.470	0.530
K83.3 Fistula of bile duct	0.000	0.470	0.530
K83.2 Perforation of bile duct	0.000	0.470	0.530
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.000	0.486	0.514
K87.1 Disorders of pancreas in diseases classified elsewhere	0.000	0.486	0.514
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.000	0.486	0.514
K83.5 Biliary cyst	0.000	0.551	0.449
K83.1 Obstruction of bile duct	0.000	0.555	0.445
K85 Acute pancreatitis	0.000	0.607	0.392
K83.0 Cholangitis	0.000	0.609	0.391
K85.1 Biliary acute pancreatitis	0.000	0.704	0.295
K85.3 Drug-induced acute pancreatitis	0.000	0.718	0.281
K85.0 Idiopathic acute pancreatitis	0.000	0.718	0.281
K85.8 Other acute pancreatitis	0.000	0.734	0.266
K85.9 Acute pancreatitis, unspecified	0.000	0.821	0.179
K85.2 Alcohol-induced acute pancreatitis	0.001	0.834	0.165
K86 Other diseases of pancreas	0.000	0.838	0.162
K86.2 Cyst of pancreas	0.000	0.882	0.117
K86.3 Pseudocyst of pancreas	0.000	0.889	0.110
K86.9 Disease of pancreas, unspecified	0.000	0.891	0.109
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.909	0.091
K26.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.056	0.944	0.000
K86.8 Other specified diseases of pancreas	0.000	0.948	0.052
K86.1 Other chronic pancreatitis	0.000	0.963	0.037
K26 Duodenal ulcer	0.026	0.974	0.000
K26.0 Acute with haemorrhage	0.023	0.977	0.000
K26.7 Chronic without haemorrhage or perforation	0.023	0.977	0.000
K26.1 Acute with perforation	0.021	0.978	0.000
K26.2 Acute with both haemorrhage and perforation	0.020	0.979	0.000
E16.2 Hypoglycaemia, unspecified	0.020	0.980	0.000
K26.5 Chronic or unspecified with perforation	0.020	0.980	0.000
K26.6 Chronic or unspecified with both haemorrhage and perforation	0.019	0.981	0.000
L81.4 Other melanin hyperpigmentation	0.017	0.983	0.000
K29.5 Chronic gastritis, unspecified	0.000	0.985	0.015
E16 Other disorders of pancreatic internal secretion	0.014	0.986	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.988	0.012
E16.0 Drug-induced hypoglycaemia without coma	0.011	0.988	0.000
N89 Other noninflammatory disorders of vagina	0.000	0.989	0.011
N89.5 Stricture and atresia of vagina	0.000	0.989	0.011
N89.6 Tight hymenal ring	0.000	0.989	0.011
E16.9 Disorder of pancreatic internal secretion, unspecified	0.010	0.990	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.010	0.990	0.000
E16.4 Abnormal secretion of gastrin	0.010	0.990	0.000
E16.3 Increased secretion of glucagon	0.010	0.990	0.000
E16.1 Other hypoglycaemia	0.010	0.990	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.000	0.991	0.009
T50.9 Other and unspecified drugs, medicaments and biological substances	0.009	0.991	0.000
K26.4 Chronic or unspecified with haemorrhage	0.009	0.991	0.000
E21.0 Primary hyperparathyroidism	0.009	0.991	0.000
N89.7 Haematocolpos	0.000	0.992	0.008
N89.4 Leukoplakia of vagina	0.000	0.992	0.008
N89.3 Dysplasia of vagina, unspecified	0.000	0.992	0.008
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.000	0.992	0.008
N89.1 Moderate vaginal dysplasia	0.000	0.992	0.008
N89.0 Mild vaginal dysplasia	0.000	0.992	0.008
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.008	0.992	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.007	0.993	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.007	0.993	0.000
T50.4 Drugs affecting uric acid metabolism	0.007	0.993	0.000
M79.54 Residual foreign body in soft tissue (Hand)	0.007	0.993	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.993	0.000
Z63.4 Disappearance and death of family member	0.000	0.993	0.007
T36-T50 Poisoning by drugs, medicaments and biological substances	0.006	0.994	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.006	0.994	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.006	0.994	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
C77.1 Intrathoracic lymph nodes	0.006	0.994	0.000
T50.8 Diagnostic agents	0.006	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
T50.5 Appetite depressants	0.006	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.006	0.994	0.000
T50.1 Loop [high-ceiling] diuretics	0.006	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.006	0.994	0.000
E21.3 Hyperparathyroidism, unspecified	0.006	0.994	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.994	0.000
K26.3 Acute without haemorrhage or perforation	0.005	0.994	0.001
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.005	0.994	0.000
T39.0 Salicylates	0.005	0.995	0.000
Z63 Other problems related to primary support group, including family circumstances	0.000	0.995	0.005
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
E15 Nondiabetic hypoglycaemic coma	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.005	0.995	0.000
E21.4 Other specified disorders of parathyroid gland	0.005	0.995	0.000
E21.2 Other hyperparathyroidism	0.005	0.995	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.995	0.005
F80.1 Expressive language disorder	0.005	0.995	0.000
Z63.0 Problems in relationship with spouse or partner	0.000	0.995	0.005
T47.0 Histamine H(2)-receptor antagonists	0.005	0.995	0.000
F43.2 Adjustment disorders	0.005	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.005	0.995	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.005	0.995	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
T39.4 Antirheumatics, not elsewhere classified	0.005	0.995	0.000
T39.2 Pyrazolone derivatives	0.005	0.995	0.000
Z63.5 Disruption of family by separation and divorce	0.000	0.995	0.005
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.005	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
T44.0 Anticholinesterase agents	0.005	0.995	0.000
Z63.7 Other stressful life events affecting family and household	0.000	0.995	0.005
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.995	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.995	0.000
F11 Mental and behavioural disorders due to use of opioids	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.995	0.000
T47.7 Emetics	0.004	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.995	0.000
T47.5 Digestants	0.004	0.995	0.000
T47.4 Other laxatives	0.004	0.995	0.000
T47.3 Saline and osmotic laxatives	0.004	0.995	0.000
T47.2 Stimulant laxatives	0.004	0.995	0.000
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.005	0.995	0.000
T36 Poisoning by systemic antibiotics	0.004	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
T38.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
T38.7 Androgens and anabolic congeners	0.004	0.996	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.004	0.996	0.000
T38.5 Other oestrogens and progestogens	0.004	0.996	0.000
T38.4 Oral contraceptives	0.004	0.996	0.000
T38.2 Antithyroid drugs	0.004	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.004	0.996	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.996	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
F10.2 Dependence syndrome	0.004	0.996	0.000
F11.0 Acute intoxication	0.004	0.996	0.000
F80 Specific developmental disorders of speech and language	0.004	0.996	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.004	0.996	0.000
Z29.2 Other prophylactic chemotherapy	0.004	0.996	0.000
Z63.9 Problem related to primary support group, unspecified	0.000	0.996	0.004
Z63.6 Dependent relative needing care at home	0.000	0.996	0.004
Z63.3 Absence of family member	0.000	0.996	0.004
Z63.2 Inadequate family support	0.000	0.996	0.004
Z63.1 Problems in relationship with parents and in-laws	0.000	0.996	0.004
L50.0 Allergic urticaria	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.004	0.996	0.000
F11.3 Withdrawal state	0.004	0.996	0.000
F05.9 Delirium, unspecified	0.004	0.996	0.000
F11.2 Dependence syndrome	0.004	0.996	0.000
Z63.8 Other specified problems related to primary support group	0.000	0.996	0.004
F12.1 Harmful use	0.004	0.996	0.000
E20-E35 Disorders of other endocrine glands	0.004	0.996	0.000
F11.1 Harmful use	0.004	0.996	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.004	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
T41.5 Therapeutic gases	0.004	0.996	0.000
T41.4 Anaesthetic, unspecified	0.004	0.996	0.000
T41.3 Local anaesthetics	0.004	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
T41.1 Intravenous anaesthetics	0.004	0.996	0.000
T41.0 Inhaled anaesthetics	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
T48.4 Expectorants	0.004	0.996	0.000
T48.3 Antitussives	0.004	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
T48.0 Oxytocic drugs	0.004	0.996	0.000
T49.9 Topical agent, unspecified	0.004	0.996	0.000
T49.8 Other topical agents	0.004	0.996	0.000
T49.7 Dental drugs, topically applied	0.004	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.996	0.000
T49.2 Local astringents and local detergents	0.004	0.996	0.000
T49.1 Antipruritics	0.004	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
F80.2 Receptive language disorder	0.004	0.996	0.000
F10.5 Psychotic disorder	0.004	0.996	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
N62 Hypertrophy of breast	0.004	0.996	0.000
F11.9 Unspecified mental and behavioural disorder	0.003	0.996	0.000
F11.8 Other mental and behavioural disorders	0.003	0.996	0.000
F11.7 Residual and late-onset psychotic disorder	0.003	0.996	0.000
F11.6 Amnesic syndrome	0.003	0.996	0.000
F11.5 Psychotic disorder	0.003	0.996	0.000
F11.4 Withdrawal state with delirium	0.003	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.996	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.003	0.996	0.000
F43 Reaction to severe stress, and adjustment disorders	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
E26 Hyperaldosteronism	0.003	0.996	0.000
F10.0 Acute intoxication	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.996	0.000
T36.8 Other systemic antibiotics	0.003	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
T36.6 Rifamycins	0.003	0.996	0.000
T36.5 Aminoglycosides	0.003	0.996	0.000
T36.4 Tetracyclines	0.003	0.996	0.000
T36.3 Macrolides	0.003	0.996	0.000
T36.2 Chloramphenicol group	0.003	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.996	0.000
M79.5 Residual foreign body in soft tissue	0.003	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
L81 Other disorders of pigmentation	0.003	0.997	0.000
E20 Hypoparathyroidism	0.003	0.997	0.000
F19.2 Dependence syndrome	0.003	0.997	0.000
F10.6 Amnesic syndrome	0.003	0.997	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.003	0.997	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.003	0.997	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.003	0.997	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.003	0.997	0.000
F10.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
F12.2 Dependence syndrome	0.003	0.997	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.003	0.997	0.000
F80.8 Other developmental disorders of speech and language	0.003	0.997	0.000
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.003	0.997	0.000
F80.0 Specific speech articulation disorder	0.003	0.997	0.000
E14.3 With ophthalmic complications	0.003	0.997	0.000
F52.2 Failure of genital response	0.000	0.997	0.003
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.003	0.997	0.000
F10.8 Other mental and behavioural disorders	0.003	0.997	0.000
F10.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
F12.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F12.8 Other mental and behavioural disorders	0.003	0.997	0.000
F12.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F12.6 Amnesic syndrome	0.003	0.997	0.000
F12.5 Psychotic disorder	0.003	0.997	0.000
F12.4 Withdrawal state with delirium	0.003	0.997	0.000
F12.3 Withdrawal state	0.003	0.997	0.000
F12.0 Acute intoxication	0.003	0.997	0.000
O80.9 Single spontaneous delivery, unspecified	0.003	0.997	0.000
Z29.8 Other specified prophylactic measures	0.003	0.997	0.000
F43.1 Posttraumatic stress disorder	0.003	0.997	0.000
M79.57 Residual foreign body in soft tissue (Ankle and foot)	0.003	0.997	0.000
F19.1 Harmful use	0.003	0.997	0.000
T36.0 Penicillins	0.003	0.997	0.000
F80-F89 Disorders of psychological development	0.003	0.997	0.000
E20.9 Hypoparathyroidism, unspecified	0.003	0.997	0.000
E26.9 Hyperaldosteronism, unspecified	0.003	0.997	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.003	0.997	0.000
E32 Diseases of thymus	0.003	0.997	0.000
E31 Polyglandular dysfunction	0.003	0.997	0.000
E30 Disorders of puberty, not elsewhere classified	0.003	0.997	0.000
E25 Adrenogenital disorders	0.003	0.997	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.003	0.997	0.000
E26.0 Primary hyperaldosteronism	0.003	0.997	0.000
F15.1 Harmful use	0.003	0.997	0.000
F22.0 Delusional disorder	0.003	0.997	0.000
F19.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F19.8 Other mental and behavioural disorders	0.003	0.997	0.000
F19.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F19.6 Amnesic syndrome	0.003	0.997	0.000
F19.5 Psychotic disorder	0.003	0.997	0.000
F19.4 Withdrawal state with delirium	0.003	0.997	0.000
F19.3 Withdrawal state	0.003	0.997	0.000
F19.0 Acute intoxication	0.003	0.997	0.000
E28 Ovarian dysfunction	0.003	0.997	0.000
Z29 Need for other prophylactic measures	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
E29 Testicular dysfunction	0.003	0.997	0.000
E34 Other endocrine disorders	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
E22 Hyperfunction of pituitary gland	0.003	0.997	0.000
F10.3 Withdrawal state	0.003	0.997	0.000
F43.9 Reaction to severe stress, unspecified	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
F10.4 Withdrawal state with delirium	0.003	0.997	0.000
E22.1 Hyperprolactinaemia	0.003	0.997	0.000
F15.9 Unspecified mental and behavioural disorder	0.003	0.997	0.000
F15.8 Other mental and behavioural disorders	0.003	0.997	0.000
F15.7 Residual and late-onset psychotic disorder	0.003	0.997	0.000
F15.6 Amnesic syndrome	0.003	0.997	0.000
F15.5 Psychotic disorder	0.003	0.997	0.000
F15.4 Withdrawal state with delirium	0.003	0.997	0.000
F15.3 Withdrawal state	0.003	0.997	0.000
F15.2 Dependence syndrome	0.003	0.997	0.000
F15.0 Acute intoxication	0.003	0.997	0.000
F43.8 Other reactions to severe stress	0.003	0.997	0.000
Z48.8 Other specified surgical follow-up care	0.003	0.997	0.000
E24 Cushing's syndrome	0.003	0.997	0.000
E26.8 Other hyperaldosteronism	0.003	0.997	0.000
E26.1 Secondary hyperaldosteronism	0.003	0.997	0.000
F22 Persistent delusional disorders	0.003	0.997	0.000
F44 Dissociative [conversion] disorders	0.003	0.997	0.000
M79.59 Residual foreign body in soft tissue (Site unspecified)	0.003	0.997	0.000
M79.58 Residual foreign body in soft tissue (Other)	0.003	0.997	0.000
M79.56 Residual foreign body in soft tissue (Lower leg)	0.003	0.997	0.000
M79.55 Residual foreign body in soft tissue (Pelvic region and thigh)	0.003	0.997	0.000
M79.53 Residual foreign body in soft tissue (Forearm)	0.003	0.997	0.000
M79.52 Residual foreign body in soft tissue (Upper arm)	0.003	0.997	0.000
M79.51 Residual foreign body in soft tissue (Shoulder region)	0.003	0.997	0.000
M79.50 Residual foreign body in soft tissue (Multiple sites)	0.003	0.997	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.003	0.997	0.000
Z29.1 Prophylactic immunotherapy	0.003	0.997	0.000
L81.7 Pigmented purpuric dermatosis	0.003	0.997	0.000
L81.6 Other disorders of diminished melanin formation	0.003	0.997	0.000
L81.5 Leukoderma, not elsewhere classified	0.003	0.997	0.000
L81.3 Cafe au lait spots	0.003	0.997	0.000
L81.1 Chloasma	0.003	0.997	0.000
L81.0 Postinflammatory hyperpigmentation	0.003	0.997	0.000
E20.8 Other hypoparathyroidism	0.003	0.997	0.000
E20.1 Pseudohypoparathyroidism	0.003	0.997	0.000
E20.0 Idiopathic hypoparathyroidism	0.003	0.997	0.000
F13.9 Unspecified mental and behavioural disorder	0.002	0.997	0.000
F13.8 Other mental and behavioural disorders	0.002	0.997	0.000
F13.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
F13.6 Amnesic syndrome	0.002	0.997	0.000
F13.5 Psychotic disorder	0.002	0.997	0.000
F13.4 Withdrawal state with delirium	0.002	0.997	0.000
F13.3 Withdrawal state	0.002	0.997	0.000
F13.2 Dependence syndrome	0.002	0.997	0.000
F13.1 Harmful use	0.002	0.997	0.000
F13.0 Acute intoxication	0.002	0.997	0.000
F14.9 Unspecified mental and behavioural disorder	0.002	0.997	0.000
F14.8 Other mental and behavioural disorders	0.002	0.997	0.000
F14.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
F14.6 Amnesic syndrome	0.002	0.997	0.000
F14.5 Psychotic disorder	0.002	0.997	0.000
F14.4 Withdrawal state with delirium	0.002	0.997	0.000
F14.3 Withdrawal state	0.002	0.997	0.000
F14.2 Dependence syndrome	0.002	0.997	0.000
F14.1 Harmful use	0.002	0.997	0.000
F14.0 Acute intoxication	0.002	0.997	0.000
F16.9 Unspecified mental and behavioural disorder	0.002	0.997	0.000
F16.8 Other mental and behavioural disorders	0.002	0.997	0.000
F16.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
F16.6 Amnesic syndrome	0.002	0.997	0.000
F16.5 Psychotic disorder	0.002	0.997	0.000
F16.4 Withdrawal state with delirium	0.002	0.997	0.000
F16.3 Withdrawal state	0.002	0.997	0.000
F16.2 Dependence syndrome	0.002	0.997	0.000
F16.1 Harmful use	0.002	0.997	0.000
F16.0 Acute intoxication	0.002	0.997	0.000
F18.9 Unspecified mental and behavioural disorder	0.002	0.997	0.000
F18.8 Other mental and behavioural disorders	0.002	0.997	0.000
F18.7 Residual and late-onset psychotic disorder	0.002	0.997	0.000
F18.6 Amnesic syndrome	0.002	0.997	0.000
F18.5 Psychotic disorder	0.002	0.997	0.000
F18.4 Withdrawal state with delirium	0.002	0.997	0.000
F18.3 Withdrawal state	0.002	0.997	0.000
F18.2 Dependence syndrome	0.002	0.997	0.000
F18.1 Harmful use	0.002	0.997	0.000
F18.0 Acute intoxication	0.002	0.997	0.000
E23 Hypofunction and other disorders of pituitary gland	0.003	0.997	0.000
E28.2 Polycystic ovarian syndrome	0.003	0.997	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.001	0.997	0.002
F40-F48 Neurotic, stress-related and somatoform disorders	0.003	0.997	0.000
Chapter V Mental and behavioural disorders	0.003	0.997	0.000
F44.8 Other dissociative [conversion] disorders	0.002	0.997	0.000
F84 Pervasive developmental disorders	0.002	0.997	0.000
F44.4 Dissociative motor disorders	0.002	0.997	0.000
L81.2 Freckles	0.002	0.997	0.000
F25 Schizoaffective disorders	0.002	0.997	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.003	0.997	0.000
F89 Unspecified disorder of psychological development	0.002	0.997	0.000
F88 Other disorders of psychological development	0.002	0.997	0.000
F83 Mixed specific developmental disorders	0.002	0.997	0.000
F82 Specific developmental disorder of motor function	0.002	0.997	0.000
E25.9 Adrenogenital disorder, unspecified	0.002	0.997	0.000
E25.8 Other adrenogenital disorders	0.002	0.997	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.002	0.997	0.000
E30.9 Disorder of puberty, unspecified	0.002	0.997	0.000
E30.8 Other disorders of puberty	0.002	0.997	0.000
E30.1 Precocious puberty	0.002	0.997	0.000
E30.0 Delayed puberty	0.002	0.997	0.000
E31.9 Polyglandular dysfunction, unspecified	0.002	0.997	0.000
E31.8 Other polyglandular dysfunction	0.002	0.997	0.000
E31.1 Polyglandular hyperfunction	0.002	0.997	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.997	0.000
E32.9 Disease of thymus, unspecified	0.002	0.997	0.000
E32.8 Other diseases of thymus	0.002	0.997	0.000
E32.1 Abscess of thymus	0.002	0.997	0.000
E32.0 Persistent hyperplasia of thymus	0.002	0.997	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.002	0.997	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.002	0.997	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.002	0.997	0.000
F05.0 Delirium not superimposed on dementia, so described	0.002	0.997	0.000
E27 Other disorders of adrenal gland	0.002	0.997	0.000
F48 Other neurotic disorders	0.002	0.997	0.000
E10.9 Without complications	0.003	0.997	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.002	0.997	0.000
F25.1 Schizoaffective disorder, depressive type	0.002	0.998	0.000
F44.5 Dissociative convulsions	0.002	0.998	0.000
F44.0 Dissociative amnesia	0.002	0.998	0.000
F22.9 Persistent delusional disorder, unspecified	0.002	0.998	0.000
E28.9 Ovarian dysfunction, unspecified	0.002	0.998	0.000
E28.8 Other ovarian dysfunction	0.002	0.998	0.000
E28.1 Androgen excess	0.002	0.998	0.000
E28.0 Oestrogen excess	0.002	0.998	0.000
F05.8 Other delirium	0.002	0.998	0.000
Z29.9 Prophylactic measure, unspecified	0.002	0.998	0.000
F48.0 Neurasthenia	0.002	0.998	0.000
L81.8 Other specified disorders of pigmentation	0.002	0.998	0.000
E29.9 Testicular dysfunction, unspecified	0.002	0.998	0.000
E29.8 Other testicular dysfunction	0.002	0.998	0.000
E29.0 Testicular hyperfunction	0.002	0.998	0.000
E34.9 Endocrine disorder, unspecified	0.002	0.998	0.000
E34.8 Other specified endocrine disorders	0.002	0.998	0.000
E34.5 Androgen resistance syndrome	0.002	0.998	0.000
E34.4 Constitutional tall stature	0.002	0.998	0.000
E34.3 Short stature, not elsewhere classified	0.002	0.998	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.002	0.998	0.000
E34.1 Other hypersecretion of intestinal hormones	0.002	0.998	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.002	0.998	0.000
E22.8 Other hyperfunction of pituitary gland	0.002	0.998	0.000
F05.1 Delirium superimposed on dementia	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.002	0.998	0.001
F01 Vascular dementia	0.002	0.998	0.000
F10.1 Harmful use	0.002	0.998	0.000
F44.9 Dissociative [conversion] disorder, unspecified	0.002	0.998	0.000
E24.8 Other Cushing's syndrome	0.002	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.002	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.002	0.998	0.000
E24.1 Nelson's syndrome	0.002	0.998	0.000
F22.8 Other persistent delusional disorders	0.002	0.998	0.000
F44.7 Mixed dissociative [conversion] disorders	0.002	0.998	0.000
F44.6 Dissociative anaesthesia and sensory loss	0.002	0.998	0.000
F44.3 Trance and possession disorders	0.002	0.998	0.000
F44.2 Dissociative stupor	0.002	0.998	0.000
F44.1 Dissociative fugue	0.002	0.998	0.000
F01.9 Vascular dementia, unspecified	0.002	0.998	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.998	0.000
F23 Acute and transient psychotic disorders	0.002	0.998	0.000
E22.0 Acromegaly and pituitary gigantism	0.002	0.998	0.000
E29.1 Testicular hypofunction	0.002	0.998	0.000
F25.9 Schizoaffective disorder, unspecified	0.002	0.998	0.000
N03.9 Unspecified	0.000	0.998	0.002
E34.0 Carcinoid syndrome	0.002	0.998	0.000
F84.5 Asperger's syndrome	0.002	0.998	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.002	0.998	0.000
E23.1 Drug-induced hypopituitarism	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations